This document discusses Mirena, a levonorgestrel-releasing intrauterine system, as an alternative to hysterectomy for treating heavy menstrual bleeding. It provides evidence that Mirena is as effective as endometrial ablation and more effective than oral medications in reducing bleeding. Mirena has additional benefits of reversible contraception and poses fewer risks than hysterectomy. The document outlines counseling points for addressing common patient concerns with Mirena like initial irregular bleeding or amenorrhea. It promotes Mirena as a cost-effective first-line treatment that can prevent unnecessary hysterectomies in many cases.